{"organizations": [], "uuid": "704850aed4999f7f2fd2f59c5d2a1003525ff86f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-covance-forms-immunology-immunotox/brief-covance-forms-immunology-immunotoxicology-unit-focused-on-biologic-drug-development-idUSFWN1QR0G5", "country": "US", "domain_rank": 408, "title": "BRIEF-Covance Forms Immunology & Immunotoxicology Unit Focused On Biologic Drug Development", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-09T15:47:00.000+02:00", "replies_count": 0, "uuid": "704850aed4999f7f2fd2f59c5d2a1003525ff86f"}, "author": "", "url": "https://www.reuters.com/article/brief-covance-forms-immunology-immunotox/brief-covance-forms-immunology-immunotoxicology-unit-focused-on-biologic-drug-development-idUSFWN1QR0G5", "ord_in_thread": 0, "title": "BRIEF-Covance Forms Immunology & Immunotoxicology Unit Focused On Biologic Drug Development", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-covance forms immunology & immunotoxicology", "sentiment": "negative"}, {"name": "brief-covance forms immunology & immunotoxicology un", "sentiment": "negative"}, {"name": "labcorp", "sentiment": "none"}, {"name": "reuters) - laboratory corporation of america holdings", "sentiment": "none"}, {"name": "covance", "sentiment": "none"}, {"name": "biologic drug development reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 9 (Reuters) - Laboratory Corporation Of America Holdings:\n* COVANCE FORMS IMMUNOLOGY & IMMUNOTOXICOLOGY UNIT FOCUSED ON BIOLOGIC DRUG DEVELOPMENT\n* LABCORP - COVANCE DRUG DEVELOPMENT BUSINESS HAS FORMED A GLOBAL IMMUNOLOGY AND IMMUNOTOXICOLOGY UNIT Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-03-09T15:47:00.000+02:00", "crawled": "2018-03-09T15:53:46.020+02:00", "highlightTitle": ""}